论文部分内容阅读
近年我院在一般常规治疗的基础上,加用藻酸双酯钠治疗慢性肺心病急性发作期病人40例,疗效满意,报道如下。 资料与方法 一、一般资料:对象为我院1988年～1993年住院的慢性肺心病急性发作期病人计78例,均符合1977年全国第二次肺心病专业会议制订的诊断标准。按入院先后及病情轻重程度将78例病人分为治疗组40例,对照组38例。治疗组:男32例,女8例,平均年龄63.5岁,Ⅱ型呼衰32例,Ⅱ度以上心衰30例;对照组:男31例,女7例,平均年龄62岁,Ⅱ型呼衰30例,Ⅱ度以上心衰28例,两组患者在性别、年龄、病程及病情严重程度方面有可比性。
In recent years, our hospital in general conventional treatment, based on the addition of sodium alginate in patients with chronic pulmonary heart disease in 40 patients with acute attack, the results are satisfactory, are reported below. Materials and Methods First, the general information: The object for our hospital from 1988 to 1993 were hospitalized in patients with acute episodes of chronic pulmonary heart disease in 78 cases, are in line with the 1977 National Conference on the diagnosis of pulmonary heart disease professional standards. 78 patients were divided into treatment group (n = 40) and control group (n = 38) according to the degree of admission and severity of illness. Treatment group: 32 males and 8 females, mean age 63.5 years old, 32 cases of type Ⅱ respiratory failure, grade Ⅱ and above 30 cases of heart failure; control group: 31 males and 7 females, mean age 62 years, type Ⅱ call 30 cases of decline, Ⅱ degree 28 cases of heart failure, two groups of patients in terms of gender, age, duration and severity of the disease are comparable.